Reply to Fitzmaurice et al.: The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay

Affiliations

Comment

Gerard J Criner et al. Am J Respir Crit Care Med. 2018.

. 2018 Dec 15;198(12):1587-1588.

doi: 10.1164/rccm.201808-1477LE.

No abstract available

Comment on

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group. Criner GJ, et al. Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164. doi: 10.1164/rccm.201803-0590OC. Am J Respir Crit Care Med. 2018. PMID: 29787288 Clinical Trial.
The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay.
Fitzmaurice GJ, Lau K, Redmond KC. Fitzmaurice GJ, et al. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1586-1587. doi: 10.1164/rccm.201807-1396LE. Am J Respir Crit Care Med. 2018. PMID: 30230346 Free PMC article. No abstract available.

1. Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, et al. LIBERATE Study Group. A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE) Am J Respir Crit Care Med. 2018;198:1151–1164. - PubMed
1. Kwiatt M, Tarbox A, Seamon MJ, Swaroop M, Cipolla J, Allen C, et al. Thoracostomy tubes: a comprehensive review of complications and related topics. Int J Crit Illn Inj Sci. 2014;4:143–155. - PMC - PubMed
1. Chen YF, Chen CY, Hsu CL, Yu CJ. Malpositioning of the chest tube across the anterior mediastinum is risky in chronic obstructive pulmonary disease patients with pneumothorax. Interact Cardiovasc Thorac Surg. 2011;13:109–111. - PubMed